Literature DB >> 18351318

[Cryoablation of prostate cancer].

U K F Witzsch1, K Skriapas, E Becht.   

Abstract

Because of continuous technical development for more than half a century, followed by better clinical results with minimal side effects, cryoablation of the prostate for localized prostate cancer has evolved as a true alternative therapeutic option in selected cases. Today's form of cryotherapy has almost nothing in common with those versions established in the 1970s and further developed in the 1990s. Nowadays it shows minimal invasiveness and high efficacy for treatment of high-risk carcinomas and failures of other therapeutic modalities. Cryoablation of the prostate is indicated if there are absolute or relative contraindications for radical surgery. In localized prostate cancer, cryoablation is the therapy of choice for salvage cases; standardisation of the procedure, definition of freeze-thaw cycles, and structured training programs have led to this status.

Entities:  

Mesh:

Year:  2008        PMID: 18351318     DOI: 10.1007/s00120-008-1660-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

Review 1.  Mechanisms of tissue injury in cryosurgery.

Authors:  A A Gage; J Baust
Journal:  Cryobiology       Date:  1998-11       Impact factor: 2.487

Review 2.  Cryoablation for carcinoma of the prostate.

Authors:  B G Patel; C L Parsons; M Bidair; J D Schmidt
Journal:  J Surg Oncol       Date:  1996-12       Impact factor: 3.454

3.  Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate.

Authors:  J P Long; D Bahn; F Lee; K Shinohara; D O Chinn; J N Macaluso
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

4.  Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results.

Authors:  A Zisman; A J Pantuck; J K Cohen; A S Belldegrun
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

5.  Prospective trial of cryosurgical ablation of the prostate: five-year results.

Authors:  B J Donnelly; J C Saliken; D S Ernst; N Ali-Ridha; P M A Brasher; J W Robinson; J C Rewcastle
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

Review 6.  The current and potential role of cryoablation as a primary therapy for localized prostate cancer.

Authors:  Aaron E Katz; John C Rewcastle
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

7.  Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells.

Authors:  K Tatsutani; B Rubinsky; G Onik; R Dahiya
Journal:  Urology       Date:  1996-09       Impact factor: 2.649

8.  Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.

Authors:  Erica H Lambert; Kimberly Bolte; Puneet Masson; Aaron E Katz
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

Review 9.  The cryobiology of cryosurgical injury.

Authors:  Nathan E Hoffmann; John C Bischof
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

10.  Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas.

Authors:  Shmuel Cytron; Adrian Paz; Sergei Kravchick; Dimitri Shumalinski; Jan Moore
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

View more
  2 in total

1.  Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience.

Authors:  Salvatore Masala; Orazio Schillaci; Alberto D Bartolucci; Ferdinando Calabria; Matteo Mammucari; Giovanni Simonetti
Journal:  Skeletal Radiol       Date:  2010-05-20       Impact factor: 2.199

2.  18F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results.

Authors:  Juliana Romanato; Marcos Roberto Menezes; Allan de Oliveira Santos; Regis Otaviano Franca Bezerra; Mariana Cunha Lopes Lima; Elba Etchebehere
Journal:  Radiol Bras       Date:  2019 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.